APT Medical Inc. APT Medical Inc.

APT Medical Inc.

688617

Rangering i aksjer #3232
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
Aksjekurs
$38.62
Markedsverdi
$5.47B
Endring (1 dag)
0.19%
Endring (1 år)
-17.07%
Land
CN
Handel APT Medical Inc. (688617)

Kategori

Healthcare
Inntekter for APT Medical Inc. (688617)
Inntekter i Jun 2026 TTM: $158.75M
Ifølge APT Medical Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat $158.75M. I 2024 hadde selskapet et resultat på $102.20M, en økning sammenlignet med resultatet i 2023, som var $84.25M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for APT Medical Inc. fra 2017 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $158.75M 18.63%
2025 $133.82M 30.94%
2024 $102.20M 21.31%
2023 $84.25M 47.08%
2022 $57.28M 64.33%
2021 $34.86M 87.86%
2020 $18.55M 41.43%
2019 $13.12M 288.78%
2018 $3.37M -29.16%
2017 $4.76M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$6.56B 4,033.47%
US
$6.60B 4,059.29%
IE
$5.15B 3,142.78%
US
$3.86B 2,332.08%
US
$3.25B 1,947.21%
DE